Abstract 6177: ATRN-119 and ATRN-W1051: Novel and potentially well tolerated ATR and WEE1 inhibitors for targeted cancer treatment

Authors: Joseph Vacca, Stephen Rocca, Justin Frye, Steven J. Schnell, Molly Hansbarger, Gregory Korbel, Fiona Simpkins, Eric J. Brown, Oren Gilad

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-6177

Source: Full article